Clinical Trial Update: REtinal Markers In Neuroinflammatory Diseases ("REMIND")

View source ↗

Summary

The REMIND clinical trial at University Hospital Basel is currently recruiting to study retinal markers in multiple sclerosis and other neuroinflammatory diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Multiple Sclerosis, Neuroinflammatory Diseases | Status: RECRUITING